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CRITICAL ISSUES IN ULCER PREVENTION IN
POSTTHROMBOTIC DISEASE
—Seshadri Raju, MD, Flowood, Miss
Postthrombotic syndrome (PTS) is a major source of
venous ulcers accounting for an estimated 	50% as caus-
ative etiology. A total of 1% to 7% of patients with PTS are
estimated to develop an ulcer in 5 to 10 years, but the true
incidence is not known as recurrent thrombosis is a major
factor in PTS development (grade 1).1 Recurrent throm-
boses are known to occur years and even decades later2,3
making accurate estimation of true PTS and ulcer incidence
impossible as a practical matter.
For purposes of this article, we will assume that any
reduction in overall incidence of PTS will also result in ulcer
prevention as ulcer-specific data is nonexistent.We examine
below known and potential avenues of preventing or con-
trolling PTS symptoms.
ANTICOAGULATION
Prevention of recurrent thrombosis will likely reduce
eventual ulcer incidence.4 This rests on proper use of
anticoagulation in vulnerable subsets to prevent recurrent
thromboses; permanent anticoagulation may be indicated.
Predisposing factors for recurrent thrombosis includes un-
provoked thromboembolism (grade 1),1,5 incomplete res-
olution of initial thrombus (grade 1),6,7 chronic venous
disease (grade 1), thrombophilia,1,2 obesity, female gen-
der, and age.2,8 There is some dispute regarding the rele-
vancy of the last four factors in recurrent thrombosis or
development of PTS.9,10 Initial severity of symptoms is a
predictor for development of PTS (grade 3).8,11 A number
of newer anticoagulants that are easier to administer, mon-
itor, and regulate are likely to come on stream in the near
future. This will likely make it easier to prevent recurrent
thromboses. Speedy approval of effective drugs should be
encouraged. Several such agents have been shown to be
effective in Europe but face delay and hurdles for United
States approval.
COMPRESSION
Compression stockings and assist devices12 have been
shown to have prophylactic value in several studies, some
extending 5 to 7 years (grade 1B).1,13-15 A few contradic-
tory results have been reported16,17 probably due to low
power, short follow-up, or variability of compression use
including noncompliance. Class I or II stockings are re-
quired for effective prophylaxis of PTS after venous throm-
bosis had occurred, grade 3 evidence18 and stockings fre-
quently used as prophylaxis against deep vein thrombosis
(eg, thrombo embolic deterrent hose) do not provide
adequate compression. A high percentage of patients dis-charged with compression stockings do not use them lat-
er.19,20
Current practice patterns allow considerable room for
improvement in proper prescription, usage, and compli-
ance monitoring.
LYSIS
Lytics, via systemic or catheter route, resolve throm-
bus,21 and improve long-term patency22 (grade 2). Cathe-
ter lysis has been shown to preserve valve function and
reduce reflux near term23-26 and improve quality of life at 2
years (grade 3).27 These surrogate endpoints suggest that
PTS incidence may be improved long-term as well. Defin-
itive studies are pending.
Pharmaco-mechanical thrombectomy is currently be-
ing evaluated for removal of thrombus and preliminary
results have appeared in print.28-30
PATHOLOGY
There is broad agreement that the pathology of PTS is
combined obstruction and reflux even though available
evidence is only grade 2.31-33 Respective role of reflux or
obstruction is undetermined. A large body of work spread
over the past century has clearly established the importance
of reflux in PTS. Recent grade 3 evidence has ignited
interest in the clinical importance of obstruction.34,35 Sub-
stantial clinical relief, including healing of ulceration, was
reported in a large series of 528 limbs when the obstructive
component was corrected and the reflux (severe in 59%
with 42% being axial) was left uncorrected.36 Conflicting
reports have also appeared regarding the relative impor-
tance of affected vein segments in these two pathologies
(obstruction and reflux). Regarding obstruction, attention
has focused on the proximal vein segments (iliac-femoral)
and the distal segments (popliteal-tibial); femoral vein oc-
clusion seems to be well-compensated with good collater-
alization from the deep femoral vein (grade 3).31,37 Grade
2 and 3 evidence has been presented in support of the
importance of proximal vein obstruction either alone or in
concert with distal segment in the development of
PTS.35,38-42 However, obstruction of distal vein segments
has been related to the development of PTS also (grade 3
evidence).43-46 Similarly conflicting (grade 3) data has ap-
peared regarding the relative roles of proximal or distal
segment reflux47,48 including the concept of ‘gate keeper’
valve44,49-52 in the genesis of PTS symptoms.
We have inadequate understanding of the interaction
between postthrombotic obstruction and reflux and their
relative importance. Thrombus resolution seems to spare
valve function53 in some instances and reflux seems to
occur in previously thrombosed33 and unthrombosed valve
segments as well.52,54,55 The mechanism of postthrom-
botic valve reflux seems more complex than initially ap-
pears.52,55,56 Basic science work in this area is sorely
needed. Techniques to quantify obstruction and reflux are
necessary to understand the pathology and target treat-
ment. It should be noted that current data regarding spon-
taneous thrombus resolution pertains only to morphologic
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consideration of the quality of such “recanalization.”57
Patency does not equal functional adequacy without hemo-
dynamic obstruction. Venography and duplex scans have
poor sensitivity (50%) for even morphologic obstruction
particularly of the iliac vein segment.36
Valve reconstruction can arguably heal ulcers and ame-
liorate PTS symptoms. Available data is conflicting; certain
subsets may benefit.56 Good efficacy has been shown in
repairing valves directly involved in the thrombotic process
by one group,58,59 somewhat less by another,60 and very
little by a third group.61 Evidence level is grade 3. Because
open valve reconstruction is less likely to be used in pro-
phylactic fashion in patients with PTS before actual ulcer-
ation (prevention), a noninvasive option needs to be devel-
oped. Numerous previous and ongoing attempts to
develop a minimally invasive technique have not borne
fruit. Relevant in this context is the efficacy of plain non-
valved iliac vein stenting in healing venous ulcers and
remitting PTS symptoms (evidence level grade 3).36
Saphenous ablation and superficial endoscopic perfora-
tor vein surgery are relatively ineffective in PTS (45% cu-
mulative ulcer recurrence at 2 years, evidence level grade
2.62 Considering that the techniques are minimally inva-
sive, the combination can be used as a temporizingmeasure
to achieve short-term relief. Saphenous reflux is not un-
common in PTS limbs.63 There is conflicting data on the
role of saphenous reflux as a contributor to PTS, evidence
level grade 3.47,64 There is no data on sapheneous ablation
alone for ameliorating PTS symptoms, even though it is
known to be safe in postthrombotic limbs65,66 and may
play a role in the development of PTS.48
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EVIDENCE OF PREVENTION AND
TREATMENT OF POSTTHROMBOTIC
SYNDROME
—Robert B. McLafferty, MD, Springfield, Ill
Definition and affliction. Postthrombotic syndrome
(PTS) is a chronic condition that is made up of a constel-
lation of clinical signs and symptoms of the lower extremity
that develop after deep venous thrombosis (DVT). PTS
affects upward of 20% to 50% of patients after DVT and,
